Stay updated on Guselkumab in Psoriasis: Clinical Trial
Sign up to get notified when there's something new on the Guselkumab in Psoriasis: Clinical Trial page.

Latest updates to the Guselkumab in Psoriasis: Clinical Trial page
- Check3 days agoChange DetectedA banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check9 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2 while the ClinicalTrials.gov page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check16 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1 while the page remains a 403 Forbidden error.SummaryDifference0.2%

- Check37 days agoChange DetectedThe study page now displays a 403 Forbidden error instead of the expected content, replacing the study details with an error screen and effectively hiding the trial information from view.SummaryDifference17%

- Check58 days agoChange DetectedThe page now includes an NIH grant/contract note for 2014, and the revision stamp was updated from v3.6.5 to v3.6.6.SummaryDifference0.1%

- Check80 days agoChange DetectedThe page's revision tag was updated to v3.6.5, replacing the previous v3.6.4, indicating a small update to the document metadata.SummaryDifference0.0%

Stay in the know with updates to Guselkumab in Psoriasis: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Guselkumab in Psoriasis: Clinical Trial page.